Private Capital Group, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2022$12,000
-20.0%
2060.0%0.01%
+200.0%
Q1 2022$15,000
-16.7%
206
-1.0%
0.00%
-25.0%
Q4 2021$18,000
-5.3%
208
+1.0%
0.00%0.0%
Q3 2021$19,000
-5.0%
206
-1.0%
0.00%
-20.0%
Q2 2021$20,000
-16.7%
208
-3.3%
0.01%
-16.7%
Q1 2021$24,000
-68.0%
215
-60.2%
0.01%
-57.1%
Q4 2020$75,000
+70.5%
540
-0.2%
0.01%
+55.6%
Q3 2020$44,000
+7.3%
541
+2.5%
0.01%0.0%
Q2 2020$41,000
+78.3%
528
+3.9%
0.01%
+50.0%
Q1 2020$23,000
+64.3%
508
+52.1%
0.01%
+100.0%
Q4 2019$14,000
+600.0%
334
+882.4%
0.00%
Q3 2019$2,000
-33.3%
340.0%0.00%
-100.0%
Q2 2019$3,000
+50.0%
340.0%0.00%
Q1 2019$2,000
+100.0%
340.0%0.00%
Q4 2018$1,000
-50.0%
340.0%0.00%
Q3 2018$2,0000.0%340.0%0.00%
Q2 2018$2,0000.0%340.0%0.00%
Q1 2018$2,0000.0%34
-97.7%
0.00%
Q4 2017$2,0001,5000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2019
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders